Literature DB >> 313966

Purification and properties of L cell-derived colony-stimulating factor.

A Waheed, R K Shadduck.   

Abstract

CSF was prepared by the growth of L cells in serum-free culture medium. This conditioned medium was subjected to a six-step purification schedule which included ultrafiltration, alcohol precipitation, and separation by DEAE-cellulose, Con A-Sepharose, Sephadex G-150, and sucrose density-gradient centrifugation. The resultant CSF was 1000-fold purified with 50% to 70% recovery of the starting activity. Granulocyte and macrophage colony formation was detected with 5 x 10(-12M CSF; maximum colonies were obtained with 3 ng per marrow culture. Two major peaks of activity were obtained; one was nonadherent to Con A, whereas the other was bound and specifically eluted with alpha-methylglucoside. Both fractions contained carbohydrate residues as they stained avidly with PAS, were inactivated by periodate, and showed altered electrophoretic mobility after treatment with neuraminidase. Following iodination, each purified fraction migrated in a single band in SDS-acrylamide gels. The molecular weight was estimated as 65,000 to 70,000 daltons. Following reduction with mercaptoethanol, the CSF fractions were reduced into subunits with molecular weights of approximately 35,000. These studies confirm the glycoprotein nature and subunit composition of L cell CSF. The methods described herein are useful for the purification of both the Con A-adherent and con A-nonadherent forms of CSF.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313966

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  19 in total

1.  Granulocyte-macrophage colony-stimulating factor produced by splenic T lymphocytes of mice infected with Schistosoma japonicum.

Authors:  M Owhashi; Y Nawa
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

2.  Bindarit: an anti-inflammatory small molecule that modulates the NFκB pathway.

Authors:  Eugenio Mora; Angelo Guglielmotti; Giuseppe Biondi; Paolo Sassone-Corsi
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

Review 3.  [Hematopoietic stem cells and their growth factors].

Authors:  C E Gauwerky; D W Golde
Journal:  Klin Wochenschr       Date:  1983-10-03

4.  Common pattern of two distinct types of colony-stimulating factor in human tissues and cultured cells.

Authors:  M C Wu; A A Yunis
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

5.  Hemopoietic growth factor production by a marrow adherent cell line.

Authors:  P J Quesenberry; P D Witte; K Landreth; Z X Song; H E McGrath; F M Stewart; Y X He; G B Baber; E Kleeman; D Innes
Journal:  Trans Am Clin Climatol Assoc       Date:  1986

6.  Changes in serum colony-stimulating factor and monocytic progenitor cells during Listeria monocytogenes infection in mice.

Authors:  E J Wing; A Waheed; R K Shadduck
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Role of lipopolysaccharide in regulating colony-stimulating factor-dependent macrophage proliferation in vitro.

Authors:  R N Moore; P S Steeg; D N Männel; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

8.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

Authors:  H E Broxmeyer; D E Williams; S Cooper; R K Shadduck; S Gillis; A Waheed; D L Urdal; D C Bicknell
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

9.  Analysis of colony-stimulating factors and macrophage progenitor cells in mice immunized against Listeria monocytogenes by adoptive transfer.

Authors:  E J Wing; D M Magee; L K Barczynski
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

10.  Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity.

Authors:  E J Wing; A Waheed; R K Shadduck; L S Nagle; K Stephenson
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.